Aura Biosciences Inc

NASDAQ:AURA  
16.97
+0.49 (+2.97%)
Earnings Announcements

Aura Biosciences Reports Fourth Quarter Financial Results

Published: 03/23/2022 20:29 GMT
Aura Biosciences Inc (AURA) - Aura Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights.
Aura Biosciences Inc - Believes Its Current Cash and Cash Equivalents Are Sufficient to Fund Its Operations Into 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.47

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.